| Not Yet Recruiting | The Combined Role of FAPI PET and Liquid Biopsy in the Staging and Clinical Management of Bladder Cancer - FUT NCT07257718 | Chiti Arturo | Phase 2 |
| Not Yet Recruiting | Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-oper NCT07463963 | Poitiers University Hospital | N/A |
| Not Yet Recruiting | Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer NCT07525349 | Assiut University | — |
| Not Yet Recruiting | Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bla NCT07468838 | Institut Cancerologie de l'Ouest | — |
| Not Yet Recruiting | Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors NCT06834204 | Rutgers, The State University of New Jersey | N/A |
| Recruiting | A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) NCT07419295 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC NCT07322263 | Michael A. O'Donnell | Phase 2 |
| Recruiting | Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy NCT07144319 | Photocure | — |
| Recruiting | Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer NCT07420517 | Paul Toren | Phase 2 |
| Recruiting | Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Ca NCT07475403 | Tianjin Medical University Second Hospital | Phase 2 |
| Recruiting | A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413 | IDEAYA Biosciences | Phase 1 |
| Recruiting | Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma NCT07492628 | Beijing Biotech | Phase 1 |
| Recruiting | Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring NCT07514897 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Recruiting | Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer NCT07424560 | Zhilong Dong | — |
| Not Yet Recruiting | Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy i NCT07413523 | Istituto Clinico Humanitas | N/A |
| Recruiting | KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab NCT07232602 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Not Yet Recruiting | SL-28 for Advanced Solid Tumours NCT07341737 | Second Life Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cance NCT07260162 | Institut Cancerologie de l'Ouest | Phase 1 |
| Recruiting | Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial NCT07227077 | Medical College of Wisconsin | N/A |
| Recruiting | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676 | Essen Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients NCT07231809 | AC.TA. S.r.l. | N/A |
| Not Yet Recruiting | Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) NCT07043543 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Not Yet Recruiting | Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization M NCT06986304 | Duke University | — |
| Recruiting | Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study NCT07339761 | University of Aarhus | N/A |
| Recruiting | Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy NCT07234968 | Thomas Jefferson University | N/A |
| Recruiting | A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Recruiting | Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration NCT07307456 | Changhai Hospital | Phase 2 |
| Not Yet Recruiting | Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer NCT07261592 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 1 / Phase 2 |
| Recruiting | Validity of Parametric MRI Using VIRADS NCT05783271 | Assiut University | N/A |
| Recruiting | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced NCT07217171 | EvolveImmune United, Inc | Phase 1 |
| Recruiting | Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 NCT07225127 | University of Washington | — |
| Not Yet Recruiting | Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder NCT07204301 | Western University, Canada | N/A |
| Recruiting | Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy NCT07225205 | Johns Hopkins University | N/A |
| Recruiting | Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? NCT07037589 | Vastra Gotaland Region | — |
| Not Yet Recruiting | A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Ge NCT06364904 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 3 |
| Recruiting | Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Ca NCT07187635 | Tianjin Medical University Second Hospital | N/A |
| Recruiting | Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin NCT07129993 | Daiichi Sankyo | Phase 2 / Phase 3 |
| Recruiting | Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Blad NCT07180212 | Tianjin Medical University Second Hospital | N/A |
| Enrolling By Invitation | Use of Wearables Following Cystectomy- Part II NCT07148765 | University of Pittsburgh | N/A |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496 | University of Arizona | Phase 1 / Phase 2 |
| Recruiting | The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of Hig NCT07130578 | Tianjin Medical University Second Hospital | — |
| Recruiting | Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Thera NCT07204132 | Changhai Hospital | N/A |
| Recruiting | Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors NCT07030257 | Tasca Therapeutics | Phase 1 / Phase 2 |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Not Yet Recruiting | Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer NCT07125924 | National Cancer Center, Korea | N/A |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors NCT07090499 | Pfizer | Phase 1 |
| Recruiting | Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery NCT07050771 | The Methodist Hospital Research Institute | Phase 2 |
| Recruiting | Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (N NCT06571708 | Columbia University | Phase 2 |
| Recruiting | Intervention of Bladder Cancer by CAR-T NCT03185468 | Shenzhen Geno-Immune Medical Institute | Phase 1 / Phase 2 |
| Enrolling By Invitation | Supporting Sexual Recovery in Women With Bladder Cancer NCT07091565 | King's College London | — |
| Not Yet Recruiting | Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer NCT07095751 | Chinese University of Hong Kong | N/A |
| Recruiting | Occupational Situation and Return to Work of Urological Patients NCT07088536 | Jagiellonian University | — |
| Recruiting | Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support NCT07048496 | University of Pennsylvania | N/A |
| Recruiting | TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation NCT07038928 | AstraZeneca | — |
| Recruiting | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival NCT06896162 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Suspended | Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents NCT06963346 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Recruiting | Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach f NCT06955910 | Istituto Oncologico Veneto IRCCS | — |
| Completed | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors NCT06973161 | AstraZeneca | — |
| Active Not Recruiting | Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases NCT06870253 | Pangea Laboratory LLC | — |
| Recruiting | Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Mult NCT07111364 | Peking University First Hospital | — |
| Not Yet Recruiting | Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer NCT06957561 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Recruiting | Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer NCT06586255 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Recruiting | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies NCT07327489 | Elephas | — |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Recruiting | Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer NCT06470282 | University of California, San Francisco | Phase 1 / Phase 2 |
| Recruiting | Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic NCT06926374 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer NCT06310369 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Recruiting | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863 | Clasp Therapeutics, Inc. | Phase 1 |
| Recruiting | The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging NCT06763354 | RenJi Hospital | N/A |
| Completed | Closed-System Bladder Irrigation to Reduce Urinary Tract Infections After Endoscopic Urologic Surgery (IRIS Tr NCT07510685 | University of Pisa | N/A |
| Recruiting | Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study NCT06337942 | University of California, Los Angeles | N/A |
| Not Yet Recruiting | Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Re NCT06762925 | Xijing Hospital | — |
| Recruiting | Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS) NCT06721260 | University of Kansas Medical Center | — |
| Recruiting | Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Effica NCT06493370 | University of Kansas Medical Center | Phase 2 |
| Recruiting | Telehealth Intervention for Ostomy Self-Management NCT06528990 | City of Hope Medical Center | Phase 2 |
| Recruiting | Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology. NCT07379255 | Qilu Hospital of Shandong University | — |
| Recruiting | Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladd NCT07379268 | Qilu Hospital of Shandong University | — |
| Not Yet Recruiting | Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder NCT06751667 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | N/A |
| Recruiting | Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology NCT07379281 | Qilu Hospital of Shandong University | — |
| Recruiting | Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663 | RenJi Hospital | Phase 2 / Phase 3 |
| Recruiting | Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection NCT06525571 | Johns Hopkins University | Phase 3 |
| Not Yet Recruiting | Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer NCT06528483 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Recruiting | Adaptive Radiotherapy for Genitourinary Cancers NCT07324798 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | N/A |
| Recruiting | A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer NCT06735287 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment NCT06679920 | Amsterdam UMC | N/A |
| Recruiting | Renal Retention in High Grade Upper Tract Urothelial Cancer NCT05656235 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Recruiting | A Study of Surgical Techniques During Cystectomy NCT06703476 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Enrolling By Invitation | Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02 NCT06780358 | Cystotech | N/A |
| Recruiting | First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours NCT06281080 | Chinese University of Hong Kong | N/A |
| Recruiting | The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy NCT06388720 | National Cancer Center, Korea | Phase 2 |
| Terminated | A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer NCT06580938 | Pfizer | Phase 1 |
| Recruiting | Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer NCT06488222 | University of Florida | Phase 2 |
| Not Yet Recruiting | Better in Better Out Cystectomy. NCT06694649 | Ziekenhuis Oost-Limburg | — |
| Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors NCT06617169 | Monopar Therapeutics | Phase 1 |
| Completed | The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cyst NCT06397040 | University of Pittsburgh | N/A |
| Recruiting | A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based o NCT06662071 | Qilu Hospital of Shandong University | — |
| Withdrawn | A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. NCT06422312 | Guangzhou Red Pine Medical Instrument Co., Ltd. | N/A |
| Not Yet Recruiting | Precise Neoadjuvant Chemoresection of Low Grade NMIBC NCT06227065 | University of Bern | Phase 2 |
| Recruiting | Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation NCT06719232 | Jahn Ferenc South Pest Teaching Hospital | — |
| Enrolling By Invitation | Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer NCT07180121 | Linkoeping University | — |
| Recruiting | Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer NCT05067101 | Zhujiang Hospital | N/A |
| Recruiting | Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Canc NCT06394570 | University of Texas Southwestern Medical Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer NCT06009510 | Power Life Sciences Inc. | — |
| Not Yet Recruiting | The Impact of PDD During TURB for NMIBC NCT06548438 | A.O.U. Città della Salute e della Scienza | Phase 4 |
| Active Not Recruiting | A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Blad NCT06331299 | UroGen Pharma Ltd. | Phase 3 |
| Active Not Recruiting | OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR NCT06820502 | Allama Iqbal Medical College | N/A |
| Recruiting | Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy NCT06427824 | University of Chicago | N/A |
| Recruiting | Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool NCT06878027 | Regina Elena Cancer Institute | — |
| Enrolling By Invitation | Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients NCT06541821 | Selcuk University | — |
| Recruiting | Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion NCT06689176 | Icahn School of Medicine at Mount Sinai | N/A |
| Recruiting | INSPIRE: a Multi-Cancer Early Detection Study NCT06440018 | Singlera Genomics Inc. | — |
| Recruiting | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069 | Eli Lilly and Company | Phase 1 |
| Not Yet Recruiting | Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients NCT06469229 | Changhai Hospital | — |
| Recruiting | RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients NCT06341400 | Zhujiang Hospital | Phase 1 / Phase 2 |
| Withdrawn | A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta NCT06390111 | Ferring Pharmaceuticals | Phase 4 |
| Not Yet Recruiting | Urine DNA Methylation Detection for Hematuria Evaluation NCT06427993 | Changhai Hospital | — |
| Completed | A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients NCT06002269 | University of Utah | N/A |
| Recruiting | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors NCT06337084 | Monopar Therapeutics | Phase 1 |
| Recruiting | Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory B NCT06364956 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 1 / Phase 2 |
| Active Not Recruiting | Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystec NCT06408597 | Nazmy Edward Seif | N/A |
| Recruiting | Comprehensive Optimization At-time of Radical Cystectomy Intervention NCT05714826 | University of Texas Southwestern Medical Center | N/A |
| Recruiting | Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle NCT05037279 | Verity Pharmaceuticals Inc. | Phase 3 |
| Recruiting | Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) NCT06551233 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 1 |
| Not Yet Recruiting | Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive B NCT06374914 | Dokuz Eylul University | — |
| Unknown | Antitumor T Cell Responses in Patients With Bladder Cancer NCT06334406 | Centre Hospitalier Universitaire de Besancon | — |
| Not Yet Recruiting | Pre-operative Immuno-Nutrition in Radical Cystectomy NCT06355518 | Fondazione IRCCS Policlinico San Matteo di Pavia | N/A |
| Active Not Recruiting | A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940 NCT06305767 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Unknown | Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC NCT06324058 | Huashan Hospital | N/A |
| Active Not Recruiting | Study on the Staging and Prognosis Model of Bladder Cancer NCT06565923 | The First Affiliated Hospital with Nanjing Medical University | — |
| Recruiting | Investigator Grant (IG) 2022 27746 NCT06341478 | IRCCS San Raffaele | N/A |
| Recruiting | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors NCT06257264 | BeiGene | Phase 1 |
| Recruiting | A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470 | MacroGenics | Phase 1 |
| Recruiting | Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessmen NCT06138561 | Dana-Farber Cancer Institute | — |
| Active Not Recruiting | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors NCT06238479 | Eli Lilly and Company | Phase 1 |
| Active Not Recruiting | Integrated Actionable Aging Assessment for Cancer Patients Pilot NCT05871008 | University of Colorado, Denver | N/A |
| Recruiting | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478 | Daiichi Sankyo | Phase 2 |
| Not Yet Recruiting | A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Can NCT06255964 | SUNHO（China）BioPharmaceutical CO., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Stress-reducing Intervention in Urothelial Carcinoma NCT06269536 | Comenius University | N/A |
| Recruiting | Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Ma NCT06992986 | Regina Elena Cancer Institute | — |
| Unknown | Comparison of the Application of Robot-assisted Laparoscopic Pathways in Radical Cystectomy NCT06253091 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Recruiting | A Study of Ward Admissions for Haematuria NCT07395037 | British Urology Researchers in Surgical Training | — |
| Recruiting | Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer NCT06389019 | Mingzhao Xiao | — |
| Recruiting | Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer NCT06775977 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfe NCT07051083 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Ca NCT06040762 | University of Washington | N/A |
| Active Not Recruiting | A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT NCT06111235 | CG Oncology, Inc. | Phase 3 |
| Recruiting | Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers NCT06537960 | Hopital Foch | N/A |
| Recruiting | Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm NCT05779631 | Radboud University Medical Center | N/A |
| Completed | Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT NCT05905276 | Johns Hopkins University | N/A |
| Unknown | Day-case Endourology; Patient Experience NCT06152679 | Royal Devon and Exeter NHS Foundation Trust | — |
| Completed | Clinical Investigation of the Multi4 System NCT06136312 | Multi4 Medical Ab | N/A |
| Unknown | Analyzing the Urine During BCG Instillation in Bladder Cancer Patients for Disease Followup NCT06153849 | Changhai Hospital | — |
| Unknown | Day-case Endourology; Enablers, Barriers, Unexpected Outcomes NCT06152666 | Royal Devon and Exeter NHS Foundation Trust | — |
| Enrolling By Invitation | Comparison of Apixaban Versus Enoxaparin NCT06243510 | Abramson Cancer Center at Penn Medicine | N/A |
| Recruiting | Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma NCT06091124 | RenJi Hospital | Phase 2 |
| Completed | Evaluation of VISIOCYT Bladder Cytology in Real Life NCT06072027 | Institut Paoli-Calmettes | — |
| Recruiting | Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy NCT05792722 | Johns Hopkins University | N/A |
| Completed | Retrospective Analysis of Different Quadratus Lumborum Block Techniques on Recovery Quality and Analgesic Cons NCT06851520 | Namik Kemal University | — |
| Active Not Recruiting | Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers NCT05891171 | Arcus Biosciences, Inc. | Phase 1 |
| Recruiting | A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in NCT06022029 | OncoNano Medicine, Inc. | Phase 1 |
| Recruiting | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) NCT06116019 | Charite University, Berlin, Germany | — |
| Recruiting | Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) NCT05879653 | Kyoto University Hospital | Phase 2 |
| Withdrawn | A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial NCT06301308 | Second Xiangya Hospital of Central South University | Phase 3 |
| Unknown | Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cance NCT05975151 | Qilu Hospital of Shandong University | Phase 2 |
| Withdrawn | A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer NCT03909893 | University Health Network, Toronto | N/A |
| Recruiting | Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients NCT06427291 | Fudan University | Phase 1 |
| Terminated | ADSTILADRIN Early Utilization and Outcomes in the Real World Setting NCT06026332 | Ferring Pharmaceuticals | — |
| Unknown | [68Ga] NOTA-SGC8 in the Staging of Bladder Cancer NCT06005116 | RenJi Hospital | N/A |
| Withdrawn | TAS-116 Plus Palbociclib in Breast and Rb-null Cancer NCT05655598 | Brown University | Phase 1 |
| Unknown | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of AP NCT06034015 | Jiangsu Yahong Meditech Co., Ltd aka Asieris | Phase 1 |
| Active Not Recruiting | Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder C NCT06059547 | CatalYm GmbH | Phase 2 |
| Unknown | The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients NCT06245759 | Huazhong University of Science and Technology | — |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest NCT05899361 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE) NCT06691776 | The Netherlands Cancer Institute | N/A |
| Completed | Physical Therapy in Pre-cystectomy Patients NCT05978570 | UNC Lineberger Comprehensive Cancer Center | — |
| Unknown | Influence of Anesthesia Methods on CTCs in TURBT Patients NCT05824299 | RenJi Hospital | N/A |
| Recruiting | Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer NCT06092450 | First Affiliated Hospital of Chongqing Medical University | — |
| Completed | Lymph Node Dissection Before or After Cystectomy NCT05939856 | Jagiellonian University | N/A |
| Recruiting | Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer NCT05982561 | Early is Good Inc. | — |
| Recruiting | A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767 | Memorial Sloan Kettering Cancer Center | N/A |
| Active Not Recruiting | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors NCT05858736 | OncoC4, Inc. | Phase 1 |
| Recruiting | Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform NCT05520099 | Elephas | — |
| Completed | Mobile Ostomates Resources for Patients and Caregivers NCT06157814 | Icahn School of Medicine at Mount Sinai | N/A |
| Active Not Recruiting | Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors NCT06119724 | Menoufia University | N/A |
| Completed | Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside NCT06020651 | Institut Mutualiste Montsouris | N/A |
| Terminated | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors NCT05563272 | Telix Pharmaceuticals (Innovations) Pty Ltd | Phase 2 |
| Completed | Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits NCT06193941 | Zhongnan Hospital | — |
| Unknown | RARC vs LRC in A Multicenter Cohort Study NCT05885204 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Not Yet Recruiting | Single-Dose Intravesical Chemotherapy After Diagnostic URS NCT05810623 | David D'Andrea | Phase 3 |
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid NCT05864144 | Sensei Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Safely Reduce Cystoscopic Evaluations for Hematuria Patients NCT06026189 | Erasmus Medical Center | N/A |
| Recruiting | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE NCT07403630 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Completed | The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Canc NCT06381895 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Unknown | The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 NCT05829057 | Zhejiang University | Phase 1 |
| Recruiting | Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. NCT05878964 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Bladder Cancer Screening Trial NCT05646485 | University of Texas Southwestern Medical Center | N/A |
| Unknown | Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study NCT05856825 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Withdrawn | InveStigAting Bladder fiELd-cycLing imAging NCT05846165 | University of Aberdeen | N/A |
| Terminated | Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers a NCT05819827 | Mayo Clinic | — |
| Recruiting | The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) NCT05726786 | Centre Hospitalier Universitaire Vaudois | Phase 3 |
| Unknown | Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy NCT06294054 | University Hospital, Rouen | — |
| Recruiting | Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) NCT05790850 | University of Virginia | N/A |
| Active Not Recruiting | A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guéri NCT05714202 | Janssen Research & Development, LLC | Phase 3 |
| Recruiting | Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct NCT06416319 | Universitätsmedizin Mannheim | N/A |
| Terminated | A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder NCT05699135 | Pfizer | — |
| Recruiting | Patient-Centered Surgical Prehabilitation NCT05715684 | Dana-Farber Cancer Institute | N/A |
| Enrolling By Invitation | JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer NCT05739071 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | N/A |
| Recruiting | Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids NCT05024734 | Roland Seiler-Blarer | Phase 2 |
| Recruiting | A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select S NCT05683418 | Totus Medicines | Phase 1 |
| Unknown | Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is NCT05643807 | Centre Hospitalier Universitaire Vaudois | N/A |
| Unknown | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery NCT05739812 | The Affiliated Hospital of Qingdao University | N/A |
| Unknown | Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bla NCT05697224 | Sohag University | N/A |
| Recruiting | Comprehensive Geriatric Assessment for Perioperative Optimization in Cystectomy NCT05679557 | Aarhus University Hospital | N/A |
| Recruiting | Gender Related Coping and Survivorship for Genitourinary Cancers NCT05649306 | Johns Hopkins University | — |
| Terminated | A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer NCT05568407 | Pfizer | — |
| Completed | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy NCT05630131 | UNC Lineberger Comprehensive Cancer Center | — |
| Unknown | Surgical Mesh in Radical Cystectomy to Prevent Parastomal Hernias NCT06032910 | Charles University, Czech Republic | N/A |
| Active Not Recruiting | Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unrespo NCT05704244 | Ferring Pharmaceuticals | Phase 3 |
| Recruiting | Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Ana NCT04625556 | Yonsei University | — |
| Active Not Recruiting | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) NCT05696444 | Medtronic - MITG | N/A |
| Completed | Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, P NCT05512377 | Boehringer Ingelheim | Phase 2 |
| Unknown | The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients NCT05710159 | Odense University Hospital | — |
| Active Not Recruiting | Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors NCT05544552 | Tyra Biosciences, Inc | Phase 1 / Phase 2 |
| Suspended | Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay NCT05643690 | AnchorDx Medical Co. Ltd. US | — |
| Completed | Urine VOC Investigation in Bladder Cancer Diagnosis NCT05671289 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cance NCT05600322 | Photocure | Phase 3 |
| Completed | A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) NCT05524545 | ALX Oncology Inc. | Phase 1 |
| Recruiting | A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178 | National Cancer Institute (NCI) | — |
| Completed | Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive NCT06337591 | Istituto Nazionale di Ricovero e Cura per Anziani | — |
| Unknown | Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer NCT06009848 | Tianjin Medical University Second Hospital | Phase 2 |
| Recruiting | A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer NCT05562791 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer NCT05531123 | Fudan University | Phase 2 |
| Not Yet Recruiting | A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy NCT05488353 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 4 |
| Unknown | Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder C NCT06046469 | Menoufia University | N/A |
| Unknown | Immunological Variables Associated to ICI Toxicity in Cancer Patients NCT05429866 | Jules Bordet Institute | Phase 2 |
| Recruiting | Improving Care for Rural Patients With Solid Tumors NCT04916990 | University of Colorado, Denver | N/A |
| Unknown | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer NCT05564897 | Zhejiang Cancer Hospital | Phase 2 |
| Completed | CLEAR Care Companion Application NCT05578898 | University of Michigan Rogel Cancer Center | N/A |
| Recruiting | Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer NCT06732531 | Zhuhai Beihai Biotech Co., Ltd | Phase 1 / Phase 2 |
| Completed | COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT NCT07481123 | Yavuz Saygılı | N/A |
| Unknown | Robot-assisted Urological Surgeries Using the MicroHand S Robot NCT05462392 | The Affiliated Hospital of Qingdao University | N/A |
| Unknown | A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder NCT05503563 | Assiut University | — |
| Completed | Loop Resection or Cold-cup Biopsy? A Study Comparing the Accuracy of Muscle Samples During Bladder Tumor Surge NCT06796413 | University of Stellenbosch | N/A |
| Recruiting | Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer NCT05312671 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Active Not Recruiting | Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients With MIBC NCT04630730 | Swiss Cancer Institute | Phase 2 |
| Completed | A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIB NCT05375903 | UroGen Pharma Ltd. | Phase 1 |
| Completed | Effect of Fresh Gas Flow on Emergence Time NCT05376631 | Asan Medical Center | N/A |
| Recruiting | Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence NCT05415631 | Centre Hospitalier Universitaire, Amiens | — |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Unknown | Validation Study of Uromonitor in High Risk Microhematuria Patients NCT05344937 | Clinica Universidad de Navarra, Universidad de Navarra | — |
| Unknown | Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma NCT04339933 | Ho Kyung Seo | — |
| Active Not Recruiting | A Diagnostic for the Early Detection of Bladder Cancer NCT05347342 | Cedars-Sinai Medical Center | — |
| Completed | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients NCT05253053 | TransThera Sciences (Nanjing), Inc. | Phase 1 / Phase 2 |
| Recruiting | The Man Van Project NCT06357416 | Royal Marsden NHS Foundation Trust | N/A |
| Recruiting | DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr NCT04106115 | University College, London | Phase 1 / Phase 2 |
| Withdrawn | PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer NCT05259397 | Pfizer | Phase 1 |
| Completed | Connecting Audio and Radio Sensing Systems to Improve Care at Home NCT05344950 | UNC Lineberger Comprehensive Cancer Center | — |
| Active Not Recruiting | Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC NCT05200988 | The Netherlands Cancer Institute | Phase 2 |
| Recruiting | A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China NCT05337189 | Creative Biosciences (Guangzhou) Co., Ltd. | — |
| Unknown | Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors NCT05235607 | Sichuan University | Phase 1 |
| Active Not Recruiting | A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder NCT05243550 | UroGen Pharma Ltd. | Phase 3 |
| Unknown | Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells NCT05108077 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Phase 1 / Phase 2 |
| Withdrawn | Mapping 3D Bladder NCT05260788 | University Health Network, Toronto | — |
| Recruiting | Role of Microbiome in BCG Responsiveness Prediction NCT05204199 | Cédric Poyet | — |
| Active Not Recruiting | A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer NCT04917809 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) NCT05259696 | Palleon Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Unknown | PENK Methylation Test for Detecting Bladder Cancer NCT05220189 | Asan Medical Center | — |
| Unknown | Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery NCT05392634 | N.N. Petrov National Medical Research Center of Oncology | Phase 3 |
| Completed | The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patient NCT06688643 | Xiaguang Duan | N/A |
| Active Not Recruiting | A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy NCT05055050 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | CARINAE for Stress Relief in Perioperative Care NCT05184725 | Adhera Health, Inc. | N/A |
| Completed | Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer NCT06205277 | University of Trieste | — |
| Enrolling By Invitation | The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life NCT05195515 | Aarhus University Hospital | — |
| Withdrawn | Phase I BLASST-3 Trial NCT04972253 | Guru P. Sonpavde | Phase 1 |
| Withdrawn | Comparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientif NCT04583553 | University of Kansas Medical Center | — |
| Completed | Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients W NCT04897763 | Institut Cancerologie de l'Ouest | EARLY_Phase 1 |
| Unknown | Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors NCT05148728 | Vall Hebron Insitut Recerca | N/A |
| Recruiting | Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in NCT04947059 | University of Thessaly | Phase 3 |
| Completed | Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors NCT05151341 | Institut de Cancérologie de Lorraine | N/A |
| Unknown | Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder NCT05077852 | Ankara Training and Research Hospital | — |
| Completed | Bladder Cancer and ExeRcise Training During IntraVesical ThErapy NCT04593862 | University of Alberta | Phase 2 |
| Recruiting | Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder NCT05072600 | Peking University First Hospital | Phase 2 |
| Unknown | Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized C NCT05146635 | Mansoura University | N/A |
| Completed | Gag-layer in the Urothelium of the Human Upper Urinary Tract NCT05400291 | Aarhus University Hospital | — |
| Recruiting | Infectious Complications After Cystectomy: A Prospective Observational Study NCT05153694 | Ludwig-Maximilians - University of Munich | — |
| Unknown | Can Four Weeks-check Cystoscopy and Urine Cytology After Primary Complete Resection of T1 Bladder Cancer Repla NCT05167916 | Mansoura University | N/A |
| Recruiting | Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. NCT05102110 | Origin Sciences | — |
| Completed | Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer NCT05136898 | UroGen Pharma Ltd. | Phase 3 |
| Unknown | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Cl NCT05180851 | Shanghai Fengxian District Central Hospital | EARLY_Phase 1 |
| Active Not Recruiting | MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment NCT05219734 | Invitae Corporation | — |
| Unknown | Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vacci NCT04799847 | LintonPharm Co.,Ltd. | Phase 1 / Phase 2 |
| Terminated | Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib NCT05052372 | xCures | — |
| Recruiting | Bio Clinical Collection of Urothelial Carcinoma NCT04970472 | University Hospital, Toulouse | — |
| Active Not Recruiting | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours NCT05057013 | Cancer Research UK | Phase 1 / Phase 2 |
| Recruiting | LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors NCT04979156 | University of Kansas Medical Center | — |
| Unknown | Validation of VI-RADS for the Detection of Detrusor Muscle Invasion NCT05123404 | Egyptian Biomedical Research Network | N/A |
| Completed | Outcome of Treating Bladder Cancer in Sohag University Hospital NCT05082818 | Sohag University | — |